Featured Editor

World-renowned expert in IVF, and on the editorial boards of Human Reproduction Reproductive Biotechnology Online

Dr Cummins在西澳大利亚Murdoc大学从事解剖学、人类生物学和繁殖生物技术的教学工作。在繁殖生物学和辅助生殖技术（如：体外授精）领域拥有丰富的经验。现在多个知名期刊（包括“Human Reproduction and Reproductive Biotechnology Online”）担任编辑，任西澳大利亚繁殖技术理事会科学咨询委员会主席一职（负责监督IVF诊所的政府机构）。10多年来，一直从事专业编辑工作，编辑了2500多篇论文。在亚洲拥有从多同事和朋友，曾在2005年任Osak大学染色体组信息研究中心客座教授。 2009年开始在理文从事编辑工作。

Dr Cummins teaches Anatomy, Human Biology and Reproductive Biotechnology at Murdoch University in Western Australia. He has extensive experience in reproductive biology and assisted conception techniques such as in vitro fertilization (IVF). He sits on the editorial board of several top journals, including Human Reproduction and Reproductive Biotechnology Online, and chairs the Scientific Advisory Committee of the Reproductive Technology Council of Western Australia (the government body overseeing IVF clinics). He has been involved in professional editing for 10 years and has worked on about 2500 papers. He has many colleagues and friends in Asia and was a Visiting Professor at Osaka University's Genome Information Research Center in Japan in 2005. Assoc Prof Cummins began editing for the Edanz Group in 2009.

Featured Editor

Clinical specialist in medical oncology and psychotherapy

Dr Reynolds起初从事肿瘤医学，后转为心理治疗领域。2003年退休，退休前从事临床诊疗，之后开始医学编辑生涯，大部分工作是为日本和中国作者编辑文章。Dr Reynolds是一位成功的作者，已在同行评审期刊上发表了13篇文章，还出版了两本书。2011年加盟理文编辑，担任撰稿人和编辑，除以临床医学为重点外，还编辑其它医疗领域的文稿。

Dr Reynolds initially practiced in Medical Oncology and then Psychotherapy. After retiring from clinical practice in 2003 she began a new career in medical editing. Most of her work has been for Japanese and Chinese authors. A successful author, Dr Reynolds has published 13 articles in peer-reviewed journals, and two books. Dr Reynolds joined the Edanz Group as an editor and writer in 2011 and, though with a clinical focus, works in a broad range of medical fields.

Featured Editor

Formerly a specialist Medical Indexer at Thomson Scientific

Dr Furness在格拉斯哥Beatson癌症研究院从事三年的博士后研究，此期间，利用分子遗传学技术对与癌症（如白血病）发展有关、影响造血干细胞生长的因素进行研究。后任格拉斯哥大学研究员，通过实地观察、放射同位素血液样分析和对海鸟代谢监测，分析海鸟的能量需求。Dr Furness是一位知识渊博的科技编辑，拥有大量的科技论文提炼、索引和编辑经验，涉及的领域包括通用医学、药学和遗传学，在科研实践和发表研究论文方面拥有丰富的个人经历。1993-2007年期间，在Thomson Scientific从事专家医学文摘工作，2007年起为理文编辑工作。

For three years, Dr Furness was a Post-doctoral Research Fellow at the Beatson Institute for Cancer Research, Glasgow, where she used extensive molecular genetic techniques to examine the factors influencing the growth of hematopoietic stem cells, with relevance to the development of cancers such as leukemia. Later Dr Furness was a researcher at Glasgow University where she analyzed the energetic requirements of seabirds, using field observations, analysis of radioisotopes from blood samples and metabolic monitoring of birds in respirometers. Dr Furness is a scientific editor with extensive experience of abstracting, indexing and editing scientific papers on a wide range of topics including general medicine, pharmacology and genetics, with personal experience of active scientific research and the publishing of research papers. From 1993 to 2007, Dr Furness was a Specialist Medical Indexer at Thomson Scientific. She began working with Edanz Editing in 2007.

Dr Morris拥有肿瘤学（特别是放射生物学、放射线疗法、化学疗法）专业背景。曾在牛津大学作为科研人员和首席研究员，研究癌症新药和新式放疗法的开发。近期作为医学作者和科研员，从事于生物技术的研究和著书。涉及的诊疗领域包括肿瘤、传染病、增龄性黄斑变性和肥胖。曾作为访问学者在美国Brookhaven国家实验室工作。曾在同行审查期刊杂志发表50多篇文章及专书论文。2009年开始为理文编辑工作。

Dr Morris’s scientific background is oncology with an emphasis on radiobiology, radiotherapy and chemotherapy. During the period that he worked as a scientist and principal investigator at the University of Oxford, the focus of Dr Morris’s research was on the development of new drugs and novel forms of radiotherapy for the treatment of cancer. More recently, Dr Morris has worked as a medical writer and scientist in the biotechnology industry. Therapeutic areas that he has been involved with include oncology, infectious diseases, age-related macular degeneration and obesity. Dr Morris has visiting scientist status at the Brookhaven National Laboratory in the US. Dr Morris has written over 50 peer-reviewed journal articles and book chapters. Dr Morris began working with the Edanz Group in 2009.

Dr Colebrooke的博士研究课题是“帕金森多巴胺大鼠模型的分子、神经生化和行为分析”。之后成为英国Babraham Institute分子神经科学实验室博士后研究员。熟悉各种常用实验室技术、试验和小动物模型。曾多次以第一作者身份在国际期刊杂志上发表文章。2006年开始为理文编辑工作，任编辑一职。

Dr Colebrooke’s PhD title was “Molecular, neurochemical and behavioural analyses of a novel dopamine-depleted mouse model of Parkinson’s disease.” She then was a post-doc research scientist in the Laboratory of Molecular Neuroscience, The Babraham Institute, UK. Dr Colebrooke is familiar with all the usual laboratory techniques and tests, along with small animal models. Dr Colebrooke has several first-authored publications in international journals. She began as an editor with Edanz Editing in 2006.

Dr Roth发表的文章涉及以下领域：T细胞生物学、基因重排的分子机制、发育生物学、神经生物学、核受体生物学。在转基因动物模型、开发基因组和蛋白质组技术、运用基因和蛋白质表达谱方法进行疾病诊断和治疗（包括糖尿病、肥胖、血液疾病和肿瘤）等方面拥有丰富经验。联合撰写并在影响力极高的杂志上发表了13篇文章，同时还和专利发明人联合撰写了5篇专利书。曾为知名生物制药、医疗设备和生物科技等公司提供有关平台技术和产品开发方面的顾问建议。多年担任昆尼皮亚克大学客座教授，在线授课生物学本科课程。在美国西北大学期间，获美国癌症学会博士后奖学金；在纽约冷泉港期间，研究发育神经生物学。于2010年开始为理文编辑工作，担任编辑。

Dr Roth has published articles on T cell biology, the molecular mechanisms of gene rearrangement, hematopoeisis, developmental biology, neurobiology, and nuclear receptor biology. He has extensive experience with transgeneic animal models, developing genomic and proteomic based technologies, and applying gene and protein expression profiling methods to diseases and therapeutic areas, including diabetes, obesity, blood disorders, and oncology. He is a co-author on 13 publications in high impact journals, and the co-inventor on five issued patents. He has consulted with leading biopharmaceutical, medical device, and life science companies on new platform technologies and product development. As an adjunct professor at Quinnipiac University, he taught an undergraduate online biology course for several years. He received an American Cancer Society Postdoctoral Fellowship while at Northwestern University, and studied developmental neurobiology at Cold Spring Harbor, New York. Dr Roth began working with Edanz Editing as an editor in 2010.

Dr. Dean的博士论文题目是“Endogenous Neural Excitation and Inhibition and the Evolution of Preterm Brain Injury”。目前正在从事神经系统科学领域的博士后研究工作。具有大型动物和胎儿外科手术经验，包括导管和电极置放、动物解剖、微透析和激光多普勒超 声探头立体定位。在电生理学领域里，DR. Dean具有丰富的活体电生理数据的仪器测量、记录和分析经验，包括大脑皮层脑电图棘波和癫痫发作活性、脑阻抗、脑近红外光谱(NIRS)、脑部激光多普 勒、温度、ECG、EMG、血压、超声血流量测量以及胎儿呼吸运动。此外，他还掌握系统生理学方面的知识，了解复杂和罕见的心血管和中枢神经系统反应。在 分子学领域中，Dr. Dean掌握多种印迹分析方法、引物设计和序列分析、mRNA和蛋白质提取、RT-PCR及凝胶电泳等技术。他在组织学方面的技能包括脑组织染色和分析以 及成像，对于相关的实验室技巧也具有丰富的经验。Dr. Dean从2007年期开始为Edanz Editing工作，主要编辑化学和神经系统科学领域的文章。

Dr Dean’s PhD thesis was titled “Endogenous Neural Excitation and Inhibition and the Evolution of Preterm Brain Injury.” Dr Dean is presently a post-doctoral research fellow in fields related to neuroscience. He has experience in large animal and fetal surgery techniques, including catheter and electrode placement and animal post-mortem and dissections, as well as in stereotaxic placement of microdialysis and laser Doppler probes. In electrophysiology, Dr Dean is skilled in the instrumentation, recording, and analysis of electrophysiological data in vivo, including cortical EEG spike wave and seizure activity, cerebral impedance, cerebral near-infrared spectroscopy (NIRS), cerebral laser Doppler, temperature, ECG, EMG, blood pressure, ultrasonic blood flow measurement, and fetal breathing movements. He possesses training in systems physiology, as well as an understanding of the complex and unique cardiovascular and central nervous system responses. In molecular fields, Dr Dean covers the various blot analysis techniques, primer design and sequence analysis, mRNA and protein extractions, RT-PCR and gel electrophoresis. Histology including staining and analysis of brain tissue and imaging and the associated laboratory skills are all areas in which Dr Dean has experience. Dr Dean began as an editor for Edanz Editing in 2007, and works in fields related to chemistry and neuroscience.

Dr Bradshaw是一位在生物医学科学和医疗保健领域有深厚研究功底的临床专家，欧洲医学作家协会成员，发表了17篇科技文章。2007-2008年间，当选为英国皇家内科医院指南开发小组和指导小组成员，负责指导《国家健康服务》指南的发表。还作为第一作者为英国皇家内科医学院撰写了关于“职业视力标准”，作为眼科的全国准则。在数家顶尖期刊从事同行评审工作，其中包括：《美国眼科学杂志》、《航空航天与环境医学》和《英国全科医疗学刊》。Dr Bradshaw 是医疗与生物科学的全面手专家编辑。于2010年加盟理文编辑，担任撰搞人和编辑。

Dr Bradshaw is a clinical specialist with a strong background in biomedical science and healthcare related research. He is a member of the European Medical Writers Association (EMWA), and has published over 17 scientific papers. In 2007/8, Dr Bradshaw sat on the board as an elected member of both the Royal College of Physicians guideline development and steering groups, leading to the publication of National Health Service guidelines. He also first-authored the UK national guidelines on “Occupational Visual Standards” for the Royal College of Ophthalmologists. He is a peer reviewer for several top journals including: the American Journal of Ophthalmology, Aviation Space and Environmental Medicine and the British Journal of General Practice. Dr Bradshaw is a specialist editor across a wide variety of medical and bioscience topics. He joined the Edanz Groups as an editor and writer in 2010.

Dr Charbonneau 在博士毕业后的10年里，其动物兽医实践工作涉及：普通外科，预防医学，行为辅导，另外还包括有关皮肤科、消化内科、内分泌和急诊的诊断和治疗。2000年，Dr Charbonneau 开始了又一个10年的研究，主要是急救药品和手术，并完成了为期一年的马运动器官疾病教学，授课对象为按摩疗法专业的学生。她在急诊医学方面的经验包括：外伤及心脏、肝、肾功能衰竭、感染性疾病等重症医治，复苏与输血，神经和内分泌急症，以及胃扩张及肠扭转、脾块破裂、胃肠异物、枪伤、骨折及创面修复等手术矫正。目前，Dr Charbonneau是一名救济兽医，研究领域主要是临床沟通。2011年加入理文，担任编辑。

After graduating, Dr Charbonneau spent 10 years involved in general surgery, preventive medicine, behavior counseling and diagnostics and treatments related to dermatology, gastroenterology, endocrine and emergency patients in an animal veterinary practice. In 2000, Dr Charbonneau began a 10 year focus on emergency medicine and surgery and completed a one-year term teaching equine locomotor diseases to students of massage therapy. Her experience in emergency medicine includes critical care of trauma patients and patients in cardiac, liver and renal failure, infectious disease, resuscitation and transfusion medicine, neurological and endocrine emergencies as well as surgical correction of gastric dilatation and volvulus, ruptured splenic masses, gastrointestinal foreign bodies, bullet wounds, fractures and wound repair. Currently, Dr Charbonneau works as a relief veterinarian, and has an interest in clinically focused communication. Dr Charbonneau joined Edanz as an editor in 2011.

Dr Leslie曾从事过生物化学和分子生物学研究，主要从事癌症、老化和病毒性疾病的分子生物学研究。2000年，在“日本科学与技术”基金的资助下，于神奈川县癌症研究中心研究所进行干细胞研究。次年，在东京大学进行抗癌化合物研究。随后3年内，在日本理化学研究所从事蛋白质产生与分析。2006年进入制药公司担任协调人和医学撰稿人；2010年加盟理文编辑，任撰稿人和编辑。

Dr Leslie Bestilny’s PhD was in biochemistry and molecular biology. His research focused on the molecular biology of cancer, aging and viral diseases. In 2000 he received a Japan Science and Technology (STA) scholarship to research stem cells at the Kanagawa Cancer Research Center Institute. The following year he performed research of anti-cancer compounds at The University of Tokyo. This was followed by 3 years of protein production and analysis at RIKEN Institute. He joined Pharma Inc. in 2006 as a coordinator and medical writer, and in 2010 began working with the Edanz Group as a writer and editor.

英国爱丁堡大学药理学研究员、伦敦大学和牛津大学研究助理、阿伯丁大学生理学讲师。在阿伯丁大学，她还建立了电生理实验室，用以研究药物作用与哺乳动物心室肌细胞电活动的关系。Dr Cant拥有丰富的写作和编辑经验，曾为欧共体Cordis Results and Publications数据库和BEST（英国科技专家）数据库及其在美国的姐妹数据库编辑生物和物理科学类文章。多年任Thomson Scientific医学编辑、数据库编索人，拥有心血管病学、肠胃病学、神经科学、流行病学、药理学和生理学领域的知识背景。

Dr Cant has been a Research Fellow (Pharmacology) at the University of Edinburgh and a Research Assistant at the University of London and the University of Oxford, as well as a Lecturer in Physiology at the University of Aberdeen where she also established an electrophysiology laboratory for investigation of drug effects on electrical activity in isolated mammalian cardiac ventricular cells. Dr Cant also has extensive writing and editing experience, having edited papers in biological and physical sciences for the European Community CORDIS Results and Publications databases, as well as for the BEST (British Expertise in Science and Technology) database and its sister database in the US. Dr Cant was a medical editor/database indexer for Thomson Scientific for a number of years and has a wide knowledge of various areas including cardiovascular disease, gastroenterology, neuroscience, epidemiology, pharmacology and physiology.

医学和科学编辑/撰稿人，拥有为医疗机构和药品广告研究机构进行生命科学内容开发的经验。最初任加拿大蒙特利尔戴维斯夫人医学研究院癌症研究实验室研究助理，进行分子和细胞生物学实验，内容包括：mRNA、DNA和蛋白质提纯、Northern 和Western杂交、RT - PCR、细胞运输、原代组织培养、各种药物疗效研究。还撰写了期刊杂志的投稿和向资助机构提供的实验室文件。后又从事医药广告工作8年，负责校对、审稿和事实审查；撰写了医学教育计划（向医师和护理人员传授药品标签方面的知识）。同时还是经验丰富的医学与科学自由撰稿人和编辑，为各种研究实验室和企业实体供稿。于2009年开始为理文编辑工作，担任编辑。

Ms Malapetsas is a medical and scientific editor/writer with experience in the development of content in the various areas in the life sciences for both medical research institutes and pharmaceutical advertising agencies. Initially a research assistant in a cancer research laboratory at the Lady Davis Institute for Medical Research in Montreal, Canada, she performed molecular and cellular biology experiments—including mRNA, DNA, and protein extraction and purification, Northern and Western blots, RT-PCR, cellular transport, primary tissue culture, and various drug efficacy studies. She also developed laboratory documents for submission to journals and funding agencies. Ms Malapetsas then worked in pharmaceutical advertising, where for eight years she undertook proofreading, copyediting, and fact-checking, and wrote medical education programs delivering on-label drug information to physicians and healthcare professionals. Ms Malapetsas also has extensive experience as a freelance medical and scientific editor/writer for research laboratories and corporate entities. Ms Malapetsas began working as an editor with the Edanz Group in 2009.

科技与医学作家，编辑经验涉及广泛的医学和生命科学领域。硕士论文涉及抗微生物制剂的开发，用以防治抗药性细菌。曾执教于North Carolina-Greensboro大学，讲授生物学和微生物学，同时还研究肥胖、炎症、胰岛素抵抗之间的联系。曾与他人合作撰写了7份在同行评审期刊上发表的科技文章以及一篇专书论文。持有生物医学研究生写作证书，是生命科学认证编辑（ELS）。作为编辑，编辑了数以百计的研究文章；作为作家，为药业和生物技术业编写了有关健康与医疗的文章。自2010年起为理文编辑工作，担任编辑。

Ms LaPoint is a science and medical writer-editor with experience in a wide range of medical and life science topics. Her master’s thesis involved the development of antimicrobial agents to prevent and treat antibiotic-resistant bacteria. Ms LaPoint has taught biology and microbiology at the University of North Carolina-Greensboro, where she also conducted research investigating links between obesity, inflammation, and insulin resistance. She has co-authored seven scientific manuscripts published in peer-reviewed journals and one scientific book chapter. Ms LaPoint also has a post-graduate biomedical writing certificate and is a board-certified editor in the life sciences (ELS). As an editor she has edited hundreds of research manuscripts, as a writer she has written about health and medical topics for the pharmaceutical and biotechnology industries. She began working as an editor and writer with the Edanz Group in 2010.

Dr Rogers目前任瑞士日内瓦大学科学交流与写作讲师，此前曾任生物技术行业的一个研究实验室主任一职，专门从事蛋白质组学研究，同时还从事食品行业内的初级材料研究。在巴黎大学从事博士后研究，并作为皇家学会研究员在苏塞克斯大学从事研究。发表的文章内容广泛，是七份生物技术专利的联合撰稿人。于2010年开始在理文担任编辑。

Dr Rogers presently is a lecturer in scientific communication and writing at the University of Geneva, Switzerland. He has previously held research positions as a laboratory head within the biotechnology industry, specializing in proteomics research, and within the food industry, conducting research in primary materials. He completed post-doctoral research within the University of Paris, as a Royal Society Fellow, and at the University of Sussex. He has published widely and is joint author to seven biotechnology patents. Dr Rogers began working as an editor for the Edanz Group in 2010.

2002至2009年在中国浙江大学生命科学学院担任研究员和讲师，讲授撰写和发表科技论文原则的研究生课程。2009年起，为日本一所大学的Global Center of Excellence for Asian Conservation Ecology项目提供编辑支持。研究并发表报告的领域包括与含铁血黄素沉着症（铁贮积症）有关的人类和动物医学，主要集中在生态学、农业和保护生物学领域。Wood先生还在中国第一家国家湿地公园 — 西溪国家湿地公园生态顾问小组担任组长。赴中国工作前，曾是一位灵长类动物学家，最初研究马达加斯加狐猴，后来研究旧大陆猴。一直在英国牛津布鲁克斯大学担任定期客座讲师。自2010年起在理文编辑从事编辑工作。

From 2002 to 2009, Mr Wood was a researcher and lecturer for the College of Life Sciences of Zhejiang University in China. He taught post-graduate level principles of how to write and publish scientific papers. In 2009, he began providing editorial support at a Japanese university for the Global Center of Excellence for Asian Conservation Ecology program. Mr Wood has researched and published in various fields including Hemosiderosis (Iron Storage Disease) linking human and animal medicine, his published reports have focused on ecology, agriculture and conservation biology. Mr Wood has also worked as a team leader for the ecological consultancy of China’s First National Wetland Park, Xixi Wetlands. Prior to moving to China, Mr Wood was a primatologist focusing initially on the lemurs of Madagascar but later on old world monkeys. He has been a regular visiting lecturer for Oxford Brookes University in the UK. Mr Wood began editing for the Edanz Group in 2010.

夸祖鲁纳塔尔大学实验室医学与医学科学学院人体生理系副教授,并在健康科学学院和纳尔逊曼德拉医学院教授人体生理学和人类遗传学，同时还负责基因表达实验室的运作。研究重点：高血压病以及利用药用植物进行控制高血压；先兆子痫的病因与治疗。Mackraj教授的博士后研究工作内容是基因突变近肾端小管细胞模型的生成与表征，用于肾转运机制的研究。目前的研究项目是：降血压植物的研究（重点是血管紧张素系统）、先兆子痫和当地人群的发病机制。另外，还参与了一些新药输送系统的研究项目。经常在ISI列表刊物上发表作品，是多个研究项目基金的主要获奖人。Mackraj教授2011年加盟理文编辑，担任编辑和专家评审。

Prof Mackraj is an Associate Professor in the Discipline of Human Physiology, School of Laboratory Medicine and Medical Sciences, University of Kwazulu-Natal. She teaches Human Physiology and Human Genetics at the Faculty of Health Sciences and the Nelson R Mandela School of Medicine. She is responsible for running a gene expression laboratory. Her main research focuses are hypertension and its management using medicinal plants; and the etiology and treatment of pre-eclampsia. Prof Mackraj’s postdoctoral work involved the generation and characterization of a gene-disrupted proximal tubular cell model for the investigation of transporter mechanisms in the kidney. Her current research projects involve the investigation of blood pressure lowering plants with a focus on the renin-angiotensin system; and the etiopathology of pre-eclampsia in the local population. She is also a participant in projects involving novel drug delivery systems. She is a well-published author in ISI-listed journals, and is the Principle grant-holder for her research projects. Prof Mackraj joined the Edanz Group as an editor and reviewer in 2011.

Van Dervort女士的医学编辑生涯始于在W.B. Saunders Company（Elsevier旗下）担任制作编辑期间，每年负责编辑和排版的期刊稿件高达3000多页。她培养了一批新编辑，同时还负责稿件作者和主编之间的联络协调等。她的医学出版经验涵盖了生物医学和生命科学领域。2011年加盟理文编辑，担任编辑和医学撰搞人。

Ms. Van Dervort's career in medical editing began at W.B. Saunders Company (Elsevier), where she worked as a production editor, overseeing the copyediting and production of more than 3,000 journal pages each year.  She also trained new editors and served as liaison between manuscript authors and editors-in-chief. Her experience in medical publishing covers the biomedical and life sciences fields. She joined the Edanz Group as an editor and medical writer in 2011.

从牛津大学动物学获得学士学位和博士学位后，Dr Prosser进入位于英国阿宾登医学出版公司（现隶属于Elsevier Health Sciences），担任医疗教育出版物的专职编辑。1998年起出任Medicine杂志总编，直至2006年。之后开始自由职业生涯，担任医学撰稿人和手稿编辑人。Dr Prosser是一位在生物医学和健康科学领域颇有成就和经验丰富的编辑和作家，于2006年开始供职理文集团。

After obtaining a BA and PhD in zoology from the University of Oxford, Dr Prosser joined the Medicine Publishing Company, Abingdon, UK, (now part of Elsevier Health Sciences) as a Staff Editor of medical educational publications. In 1998, she became Managing Editor of the journal Medicine, a position she held until 2006, when she began as a freelance science and medical writer and manuscript editor. Dr Prosser, an accomplished and highly experienced biomedical and health sciences editor and writer, began working with Edanz Group in 2006.

Featured Editor

Expert in models and diagnosis of Parkinson's disease

Tinsley拥有南澳弗林得斯大学医学院博士学位。研究课题为“非病毒神经胶质细胞传染：中枢神经系统再生治疗战略”。博士后工作期间，在首位证明成年人大脑中神经形成的专家Peter Eriksson教授的神经干细胞实验室工作。之后重返澳大利亚，在霍华德•弗利研究所工作，研究帕金森氏疾病的模型和诊断。拥有十多年医学研究经验，曾在知名专业期刊发表作品，包括Annals of Neurology。2011年起为理文编辑工作，担任编辑。

Dr Tinsley completed his PhD at the School of Medicine at Flinders University of South Australia. His thesis title was "Non-Viral Glial Cell Transfection: A Therapeutic Strategy for CNS Regeneration." His post-doctoral training was in the neural stem cell laboratory of Prof Peter Eriksson, the first to demonstrate neurogenesis in the adult human brain. Dr Tinsley returned to Australia to work at the Howard Florey Institute, investigating models and diagnosis of Parkinson's disease. He has over ten years experience in medical research, and has published widely in leading journals in his field, including Annals of Neurology. Dr Tinsley began working as an editor with the Edanz Group in 2011.

Dr Rice曾在纽约西奈山医学院血液/肿瘤科以及西北大学Robert H. Lurie 综合性肿瘤中心工作。博士后期间主要研究转路抑制机制，致力于t(11;17) APL中发现的PLZF和PLZF-RARa是如何通过此机制对融合癌蛋白基因表达进行调控，且在其失调后如何最终导致白血病的形成。Dr Rice曾进行过全基因筛选和相关通路及候选染色体的判定，以便针对有选择性的治疗靶向做出可检验的假设。此外，还曾与Dana-Farber癌症研究所（波士顿）和麦吉尔大学（蒙特利尔）的独立研究人员多次进行项目合作，试验癌蛋白转化细胞对特定药物配方的敏感度。曾在Blood、Genes and Development以及Blood Cancer Journal等多家国际知名期刊上发表文章，并为PNAS、Blood、Oncogene和Leukemia担任审稿人。与他人合作撰写了两篇专书论文，并在美国血液病学会的多个会议场合发表。自2011年起开始为理文编辑工作。

Dr Rice worked within the Division of Hematology/Oncology at the Mount Sinai School of Medicine in New York and at the Robert H. Lurie Comprehensive Cancer Centre of Northwestern University. Dr Rice’s Post-Doctoral studies focused on transcriptional mechanisms by which PLZF and the PLZF-RARa fusion oncoprotein found in t(11;17) APL regulate gene expression, and ultimately how their dysregulation contributes to leukemogenesis. Dr Rice has experience in performing whole genome screens and identifying relevant pathways and candidate genes to formulate testable hypothesis with the aim of selective, therapeutic targeting. She was also involved in several collaborative projects with independent researchers at the Dana-Farber Cancer Institute (Boston) and McGill University (Montreal) testing the sensitivity of oncoprotein-transformed cells to specific drug compounds. Dr Rice has published in internationally recognized journals including Blood, Genes and Development and Blood Cancer Journal and has reviewed for PNAS, Blood, Oncogene and Leukemia. She has also written two book chapters and presented her work on several occasions at American Society of Hematology meetings. Dr Rice began editing for the Edanz Group in 2011.

Milazzo先生自康奈尔大学毕业后，在一家临床前合同研究组织工作了10年，在那里负责一系列面向生物技术、制药和医疗器械企业的跨学科项目。后来在一家从事开发眼科、骨科、心血管用控释药物植入的生物技术公司任临床前研究主任，参与了多项向美国FDA提交的IND和NDA应用项目。后去新西兰攻读博士学位，曾与多家从事开发肽治疗肌肉萎缩疾病和癌症检测与监测分子诊断产品的生物技术企业合作。2010年提交了博士论文，题为“羊脂的发现 —  对皮下脂肪间充质干细胞和髌下脂肪间充质干细胞进行羊模型软骨缺损修复软骨能力方面的比较”。Milazzo先生的实验室经验涵盖了各种大型和小型研究动物模型的技术和手术技巧（尤其是骨科），其中包括：干细胞和软骨细胞的分离和培养、免疫组织化学、生化分析、组织病理标本制备与评估、显微镜技术、RNA提取和cDNA制备、基因芯片等。2011年加盟理文编辑，担任编辑。

After graduation from Cornell University, Mr Milazzo worked for 10 years at a preclinical contract research organization where he was in charge of multi-disciplinary programs for biotechnology, pharmaceutical and medical device companies. Later Mr Milazzo became the director of preclinical research for a biotechnology company developing controlled-release drug implants for ophthalmic, orthopedic, and cardiovascular use, contributing to several IND and NDA applications to the US FDA. Mr Milazzo moved to New Zealand for his PhD studies, and has been working with biotechnology companies developing peptide therapies for muscle wasting disease and molecular diagnostic products for cancer detection and monitoring. His PhD thesis submitted in 2010, was entitled "Sheep Fat Bingo - A Comparison of Subcutaneous Adipose-Derived Mesenchymal Stem Cells with Infrapatellar Adipose-Derived Mesenchymal Stem Cells with Regard to their Chondrogenic Ability in a Sheep Model of Osteochondral Defect Repair". Mr Milazzo’s laboratory expertise includes techniques and surgical skills (particularly orthopedic) associated with a variety of large and small research animal models. These include stem cell and chondrocyte isolation and culture, immunohistochemistry, biochemical assay, histopathology specimen preparation and evaluation, microscopy, RNA extraction and cDNA preparation, and gene microarray. Mr Milazzo joined the Edanz Group as an editor in 2011.

Dr Eager目前是美国德克萨斯州达拉斯的一名住院部医师。在过去10年里，已积累了丰富的临床研究和临床前研究经验，重点是肿瘤学领域。曾任玛丽克劳利癌症研究中心机构审查委员会成员6年，在此期间，审阅了大批I阶段到III阶段临床试验协议。除临床经验外，Dr Eager 还在体外临床前协议与技术、细胞培养和组织学方法等领域拥有丰富经验，拥有广博的微生物技术知识。Dr Eager撰写并合作撰写了8份出版物，起草了4份临床/临床前研究协议。Dr Eager去年一直兼职科技稿件专业编辑，2011年起加盟理文编辑，担任编辑。

Dr Eager currently practices internal medicine as a hospitalist in Dallas, Texas, USA. Over the past decade he has amassed considerable experience in clinical and pre-clinical research, principally in the field of oncology. He was a member of the Mary Crowley Cancer Research Center Institutional Review Board for six years, during which time he reviewed numerous Phase I through Phase III clinical protocols. In addition to his clinical expertise, Dr Eager has experience with in-vitro pre-clinical protocols and techniques as well as cell culture, histological methods, and animal model studies, and is skilled in a wide range of microbiology techniques. Dr Eager has authored and co-authored eight publications, and has authored four clinical or pre-clinical protocols. On a part-time basis, Dr Eager has edited scientific manuscripts professionally for the past year and began editing for the Edanz Group in 2011.